Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Behavioral or neuropsychiatric symptoms of Alzheimer’s disease: from psychopathology to pharmacological management.

Open access
Teixeira, Antonio Lucio, Rocha, Natalia Pessoa, Gatchel, Jennifer · 2023 · Arquivos de Neuro-Psiquiatria

Abstract

Neuropsychiatric or behavioral symptoms of dementia encompass a series of disorders, such as anxiety, depression, apathy, psychosis, and agitation, all commonly present in individuals living with dementia. While they are not required for the diagnosis of Alzheimer's disease (AD), they are ubiquitously present in all stages of the disease, contributing to negative clinical outcomes, including cognitive decline, functional disability, and caregiver burden. Neuropsychiatric symptoms have been conceptualized not only as risk factors but as clinical markers of decline along the AD spectrum. The concept of “mild behavioral impairment”, the behavioral correlate of mild cognitive impairment, has been proposed within this framework. The first steps in the management of behavioral symptoms in AD involve defining the target and investigating potential causes and/or aggravating factors. Once these factors are addressed, non-pharmacological approaches are preferred as first-line interventions. Following the optimization of anticholinesterase treatments, specific pharmacological approaches (e.g., antidepressants, antipsychotics) can be considered weighing potential side effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0043-1777774

Cites

Statistics

Figures

Figure 1 AD-related pathophysiological mechanisms potentially link cognitive impairment and behavioral symptoms. Proteinopathy (abnormal accumulation of amyloid-β and tau protein), neuroinflammation, and oxidative stress contribute to neuronal dysfunction and, ultimately, neuronal death in AD. The consequent neurotransmitter imbalance and neural circuit dysfunction result in cognitive impairment and behavioral symptoms. Cognitive and behavioral symptoms tend to aggravate each other.
Figure 1 AD-related pathophysiological mechanisms potentially link cognitive impairment and behavioral symptoms. Proteinopathy (abnormal accumulation of amyloid-β and tau protein), neuroinflammation, and oxidative stress contribute to neuronal dysfunction and, ultimately, neuronal death in AD. The consequent neurotransmitter imbalance and neural circuit dysfunction result in cognitive impairment and behavioral symptoms. Cognitive and behavioral symptoms tend to aggravate each other.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 88 · Cited by 33

Metadata

Authors
Teixeira, A. L., Rocha, N. P., & Gatchel, J.
Affiliations
  • University of Texas University of Texas Health Science Center, McGovern Medical School, Department of Psychiatry and Behavioral Sciences, Neuropsychiatry Program, Houston, Texas, United States.
  • University of Texas Health Science Center, McGovern Medical School, Department of Neurology, Houston, Texas, United States.
  • Michael E. DeBakey VA Medical Center (US)
Venue
Arquivos de Neuro-Psiquiatria
Published
2023-12
Volume
81
Issue
12
Pages
1152-1162
ISSN
  • 0004-282X (ISSN-L)
  • 1678-4227
OpenAlex
W4390430964
Cited by
33
References
88
Citations by year
2026: 9 · 2025: 15 · 2024: 7 · 2023: 2
FWCI
6.69
Type
journal article
Language
en
Open access
Locations
  • Arquivos de Neuro-Psiquiatria (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Texas Alzheimer's Research and Care Consortium (TARCC 2020-23-93-II)
  • National Institutes of Health
  • National Institute on Aging (K23AG058805, AG072380-01A1, R21AG072380, R01AG078191)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
Alzheimer's disease, neuropsychiatric symptoms, behavioral symptoms of dementia, agitation, psychosis, depression, anxiety, apathy, mild behavioral impairment, mild cognitive impairment, non-pharmacological treatment, cholinesterase inhibitors, antidepressants, antipsychotic drugs, caregiver burden, functional disability
MeSH terms
Alzheimer Disease, Anxiety, Mental Disorders, Behavioral Symptoms, Humans, Antipsychotic Agents, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Behavioral or neuropsychiatric symptoms of Alzheimer’s disease: from psychopathology to pharmacological management. https://app.cochat.ai/papers/10.1055/s-0043-1777774
The paper
Teixeira, A. L., Rocha, N. P., & Gatchel, J. (2023). Behavioral or neuropsychiatric symptoms of Alzheimer’s disease: from psychopathology to pharmacological management. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1055/s-0043-1777774

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.